Images can be skipped with monitors with refresh rates of both 60 Hz and 120 Hz.

Choosing a vendor for an enterprise imaging solution can be complex. Here’s what you need to inquire about to make the best choice for your organization.

15 tips for being an ideal mentor or mentee.

3D Convolutional neural network can effectively replace manual segmentation of the pancreas with or without cancer.

Using a deep convolutional neural network can improve providers’ ability to predict how patients with hepatocellular carcinoma will respond to Y90-RE treatment, enabling them to offer additional therapies, if necessary.

Incorporating artificial intelligence with TI-RADS improves sensitivity, specificity, and reduces interpretation time by nearly one-fourth.

Abdominal imaging specialist Jonathan Kruskal, M.D., Ph.D., assumed the role during the 2021 ARRS Virtual Annual Meeting.

Research findings show patient age and existing mammogram studies play a role in assessment.

Findings support the growing call to no longer require a radiologist’s presence for a barium swallow study.

Patients who have long-lasting, lingering symptoms of COVID-19 could present a growing impact on imaging services.

To successfully protect yourself from unforeseen circumstances, insurance – malpractice, life, disability, and umbrella – is vital.

Using systolic, diastolic, and mean arterial blood pressure values together results is a greater threshold for risk.

The diagnostic performance for central precocious puberty, growth hormone deficiency, and short stature is similar to that of standard contrast protocols.

The switch to using USMLE Step 2 Clinical Knowledge scores is anticipated in January 2022.

In high pre-test probability and quick RT-PCR settings, chest X-ray scoring can be predictive.

Patients want to know their risk. But, before you provide it, consider these factors to successfully integrate it into your practice.

Patients indicated breast imaging radiologists expressed more empathy over the diagnosis and had more understanding of their scans than other providers.

Although these tests are controversial, they are highly effective in identifying lumps that lead to breast cancer diagnoses.

CEM performance showed no significant difference between women with or without breast implants, and it produced very few complications.

Despite recommendations from the American College of Radiology, most providers opt to delay screening in these women.